Driven by the potential to confersafe and sustained therapeutic effects for clinical conditions unique to women,the non-hormonal therapies pipeline is growing, featuring candidates having improvedrisk profiles and lesser side effects
Roots Analysis has announced theaddition of “Non-hormonal Therapiesfor Women’s Health Market 2021 – 2030” report to its list of offerings.
In pursuit of an advantageous and risk-free prospectto hormonal therapies, the success of 21 approved non-hormonal therapies has resulted in a surge in the interest of drugdevelopers in this rapidly evolving domain. As a result, thenon-hormonal therapies market is abuzz with activity, in terms of partnershipsand funding initiatives.
Toorder this 225+ page report, which features 92+ figures and 154+ tables, pleasevisit https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market.html
Key Market Insights
Around 55non-hormonal therapies are currently being developed across different stages
Apart from 21approved products, close to 58% of the aforementioned candidates are beingevaluated in clinical stages of development, with 2% of therapies inpreclinical stages. It is worth mentioning that more than 80% of such drugs aresmall molecules. Further, majority of the therapies are being developed for thetreatment of endometriosis (19%).
Over 64% of thenon-hormonal therapy developers are based in North America
Interestingly, withinthe aforementioned region, majority of the players (21) are based in the US,which is considered a prominent R&D hub for advanced therapeutic products.Moreover, the current market is dominated by the presence of small players andvery large firms, respectively.
220+ non-hormonaltherapy focused clinical trials have been registered, worldwide
The clinical researchactivity, in terms of number of trials registered, is reported to haveincreased at a CAGR of 19% during the period 2015-2019. Of the total number oftrials, close to 83% have already been completed, while 15% studies arepresently active.
Partnership activityin this domain has grown at a CAGR of ~48%, between 2015 and 2020
Most of deals inkedin the given time period were focused on development and commercialization(26%) of non-hormonal therapies. It is further important to note that, majorityof the partnerships (7) related to such products were signed in 2020.
More than USD 800million has been invested by various investors in this market, since 2016
So far, a significantproportion of the capital has been raised through private equity (USD 262.7million). On the other hand, around USD 63.8 million was invested via venturecapital rounds, representing 8% of the total amount.
North America andEurope are anticipated to capture over 94% of the total market share, in termsof sales revenues, in 2030
In addition, smallmolecules represent a significant share of the current market, and this trendis unlikely to change in the foreseen future. In terms of route ofadministration, therapies designed for delivery via the oral route are expectedto capture the majority share of the market.
To request a samplecopy / brochure of this report, please visit https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market/request-sample.html
KeyQuestions Answered
§ Who are the leading industry players engaged in thedevelopment of non-hormonal therapies?
§ How many non-hormonal therapy candidates are present in thecurrent development pipeline? Which key women’s health related diseaseindications are targeted by such products?
§ Which commercialization strategies are most commonlyadopted by non-hormonal therapy developers, across different stages of productdevelopment?
§ Which partnership models are commonly adopted bystakeholders engaged in this domain?
§ What are the key value drivers of the merger andacquisition activity in the non-hormonal therapies industry?
§ Who are the key stakeholders that have actively madeinvestments in the non-hormonal therapy domain?
§ How is the current and future market opportunity likely tobe distributed across key market segments?
The USD 10.5+ billion (by 2030) financialopportunity associated with non-hormonal therapies market has been analyzed across the following segments:
§ TargetIndication
§ Bacterialvaginosis
§ Contraception
§ Endometriosis
§ PostmenopausalOsteoporosis
§ Uterinefibroids
§ Vaginitis
§ Others
§ Type of Molecule
§ Biologics
§ Smallmolecules
§ Route of Administration
§ Intramuscular
§ Intravaginal
§ Intravenous
§ Oral
§ Subcutaneous
§ Topical
§ Transdermal
§ Others
§ KeyGeographical Regions
§ North America
§ Europe
§ Asia-Pacific
The research includesbrief profiles of key players (listed below), engaged in the developmentof non-hormonal therapies; each profile features an overview of the therapy,current development status, clinical trials and their results (if available),target indication, route of administration and recent developments (ifavailable).
§ AbbVie
§ AstellasPharma
§ Bayer
§ DaréBioscience
§ EvofemBioscience
§ FougeraPharmaceuticals
§ Inmunotek
§ MycoviaPharmaceuticals
§ MyovantSciences
§ ObsEva
§ RadiusHealth
§ Scynexis
For additionaldetails, please visit
https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market.html oremail sales@rootsanalysis.com
You may also beinterested in the following titles:
1. RNA Targeting SmallMolecules Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030
2. Top Selling BiologicsMarket: Industry Trends and Global Forecasts, 2021-2030
3. Peptide TherapeuticsMarket: Industry Trends and Global Forecasts, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
